Publications
Detailed Information
CHEMOTHERAPY-ASSOCIATED HEPATOPATHY IN COLORECTAL CANCER LIVER METASTASIS PATIENTS
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, S. J. | - |
dc.contributor.author | Kim, H. | - |
dc.contributor.author | Cho, J. Y. | - |
dc.contributor.author | Lee, H. E. | - |
dc.contributor.author | Jang, J. J. | - |
dc.contributor.author | Choe, G. | - |
dc.contributor.author | Lee, H. S. | - |
dc.date.accessioned | 2012-06-28T05:34:54Z | - |
dc.date.available | 2012-06-28T05:34:54Z | - |
dc.date.issued | 2010-04 | - |
dc.identifier.citation | JOURNAL OF HEPATOLOGY; Vol.52 ; S443-S443 | ko_KR |
dc.identifier.issn | 0168-8278 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77763 | - |
dc.description.abstract | Background and Aims: Oxaliplatin, irinotecan and 5-fluorouracil
(5-FU)-based preoperative chemotherapy is increasingly used in patients with colorectal cancer liver metastases (CRLM). Although chemotherapy-related hepatopathy (CAH) has been described, its impact on postoperative outcome remains controversial. The purpose of our study was to review the effects of preoperative chemotherapy in CRLM patients on liver histology and on postoperative outcome. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER SCIENCE BV | ko_KR |
dc.title | CHEMOTHERAPY-ASSOCIATED HEPATOPATHY IN COLORECTAL CANCER LIVER METASTASIS PATIENTS | ko_KR |
dc.type | Conference Paper | ko_KR |
dc.citation.journaltitle | JOURNAL OF HEPATOLOGY | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.